Page 839 - Textbook of Pathology, 6th Edition
P. 839

823







































           Figure 27.25  Pathophysiological basis of common signs and symptoms due to uncontrolled hyperglycaemia in diabetes mellitus.  CHAPTER 27


            4. ββ ββ β-cell degranulation:  In type 1 DM,  EM shows  diseases and symptoms, especially due to complications.
            degranulation of remaining β-cells of islets.      Two main types of DM can be distinguished clinically to
            In type 2 DM, no such change is observed.          the extent shown in Table 27.6. However, overlapping of
                                                               clinical features occurs as regards the age of onset, duration
           Clinical Features                                   of symptoms and family history. Pathophysiology in
           It can be appreciated that  hyperglycaemia in DM does not  evolution of clinical features is schematically shown in  The Endocrine System
           cause a single disease but is associated with numerous  Fig. 27.25.

            TABLE 27.6: Contrasting Features of Type 1 and Type 2 Diabetes Mellitus.
                Feature                        Type 1 DM                           Type 2 DM
            1.  Frequency                      10-20%                              80-90%
            2.  Age at onset                   Early (below 35 years)              Late (after 40 years)
            3.  Type of onset                  Abrupt and severe                   Gradual and insidious
            4.  Weight                         Normal                              Obese/non-obese
            5.  HLA                            Linked to HLA DR3, HLA DR4, HLA DQ  No HLA association
            6.  Family history                 < 20%                               About 60%
            7.  Genetic locus                  Unknown                             Chromosome 6
            8.  Diabetes in identical twins    50% concordance                     80% concordance
            9.  Pathogenesis                   Autoimmune destruction of β-cells   Insulin resistance, impaired insulin
                                                                                   secretion
           10.  Islet cell antibodies          Yes                                 No
           11.  Blood insulin level            Decreased insulin                   Normal or increased insulin
           12.  Islet cell changes             Insulitis, β-cell depletion         No insulitis, later fibrosis of islets
           13.  Amyloidosis                    Infrequent                          Common in chronic cases
           14.  Clinical management            Insulin and diet                    Diet, exercise, oral drugs, insulin
           15.  Acute complications            Ketoacidosis                        Hyperosmolar coma
   834   835   836   837   838   839   840   841   842   843   844